GO Term	Description	P-value	FDR q-value	Enrichment	N	B	n	b	Genes
GO:0015711	organic anion transport	1.48E-9	2.04E-5	4.49	10344	272	195	23	[APOA5  -  apolipoprotein a-v, MTTP  -  microsomal triglyceride transfer protein, PLA2G2F  -  phospholipase a2, group iif, SLC16A12  -  solute carrier family 16, member 12, SLC13A2  -  solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2, LRP2  -  low density lipoprotein receptor-related protein 2, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, FABP1  -  fatty acid binding protein 1, liver, PLA2G2E  -  phospholipase a2, group iie, SLC1A2  -  solute carrier family 1 (glial high affinity glutamate transporter), member 2, CA1  -  carbonic anhydrase i, SLC16A4  -  solute carrier family 16, member 4, SLC7A9  -  solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9, CA5A  -  carbonic anhydrase va, mitochondrial, SLC4A1  -  solute carrier family 4 (anion exchanger), member 1, APOC3  -  apolipoprotein c-iii, CA7  -  carbonic anhydrase vii, SLC6A14  -  solute carrier family 6 (amino acid transporter), member 14, SLC38A8  -  solute carrier family 38, member 8, ACE2  -  angiotensin i converting enzyme 2, PLA2G1B  -  phospholipase a2, group ib (pancreas), SLC16A14  -  solute carrier family 16, member 14, SLC36A2  -  solute carrier family 36 (proton/amino acid symporter), member 2]
GO:0010951	negative regulation of endopeptidase activity	4.08E-9	2.82E-5	6.86	10344	116	195	15	[SERPIND1  -  serpin peptidase inhibitor, clade d (heparin cofactor), member 1, SERPINA6  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 6, SERPINA3  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 3, VIL1  -  villin 1, NGF  -  nerve growth factor (beta polypeptide), FABP1  -  fatty acid binding protein 1, liver, SPINK6  -  serine peptidase inhibitor, kazal type 6, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), SPP2  -  secreted phosphoprotein 2, 24kda, AHSG  -  alpha-2-hs-glycoprotein, SERPINB11  -  serpin peptidase inhibitor, clade b (ovalbumin), member 11 (gene/pseudogene), SERPINA11  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 11, AMBP  -  alpha-1-microglobulin/bikunin precursor, SERPINB7  -  serpin peptidase inhibitor, clade b (ovalbumin), member 7, SERPINB2  -  serpin peptidase inhibitor, clade b (ovalbumin), member 2]
GO:0010466	negative regulation of peptidase activity	6.57E-9	3.03E-5	6.63	10344	120	195	15	[SERPIND1  -  serpin peptidase inhibitor, clade d (heparin cofactor), member 1, SERPINA6  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 6, SERPINA3  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 3, VIL1  -  villin 1, NGF  -  nerve growth factor (beta polypeptide), FABP1  -  fatty acid binding protein 1, liver, SPINK6  -  serine peptidase inhibitor, kazal type 6, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), SPP2  -  secreted phosphoprotein 2, 24kda, AHSG  -  alpha-2-hs-glycoprotein, SERPINB11  -  serpin peptidase inhibitor, clade b (ovalbumin), member 11 (gene/pseudogene), SERPINA11  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 11, AMBP  -  alpha-1-microglobulin/bikunin precursor, SERPINB7  -  serpin peptidase inhibitor, clade b (ovalbumin), member 7, SERPINB2  -  serpin peptidase inhibitor, clade b (ovalbumin), member 2]
GO:0006820	anion transport	5.5E-8	1.9E-4	3.58	10344	356	195	24	[APOA5  -  apolipoprotein a-v, MTTP  -  microsomal triglyceride transfer protein, PLA2G2F  -  phospholipase a2, group iif, SLC16A12  -  solute carrier family 16, member 12, SLC13A2  -  solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2, LRP2  -  low density lipoprotein receptor-related protein 2, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, FABP1  -  fatty acid binding protein 1, liver, SLC1A2  -  solute carrier family 1 (glial high affinity glutamate transporter), member 2, PLA2G2E  -  phospholipase a2, group iie, CA1  -  carbonic anhydrase i, SLC12A1  -  solute carrier family 12 (sodium/potassium/chloride transporter), member 1, SLC16A4  -  solute carrier family 16, member 4, SLC7A9  -  solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9, CA5A  -  carbonic anhydrase va, mitochondrial, SLC4A1  -  solute carrier family 4 (anion exchanger), member 1, APOC3  -  apolipoprotein c-iii, CA7  -  carbonic anhydrase vii, SLC6A14  -  solute carrier family 6 (amino acid transporter), member 14, SLC38A8  -  solute carrier family 38, member 8, ACE2  -  angiotensin i converting enzyme 2, PLA2G1B  -  phospholipase a2, group ib (pancreas), SLC16A14  -  solute carrier family 16, member 14, SLC36A2  -  solute carrier family 36 (proton/amino acid symporter), member 2]
GO:0052548	regulation of endopeptidase activity	1.01E-7	2.78E-4	4.48	10344	213	195	18	[SERPIND1  -  serpin peptidase inhibitor, clade d (heparin cofactor), member 1, SERPINA6  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 6, SERPINA3  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 3, VIL1  -  villin 1, NGF  -  nerve growth factor (beta polypeptide), SPINK6  -  serine peptidase inhibitor, kazal type 6, FABP1  -  fatty acid binding protein 1, liver, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), SPP2  -  secreted phosphoprotein 2, 24kda, TP63  -  tumor protein p63, AHSG  -  alpha-2-hs-glycoprotein, TNF  -  tumor necrosis factor, SERPINB11  -  serpin peptidase inhibitor, clade b (ovalbumin), member 11 (gene/pseudogene), SERPINA11  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 11, AMBP  -  alpha-1-microglobulin/bikunin precursor, SERPINB7  -  serpin peptidase inhibitor, clade b (ovalbumin), member 7, SERPINB2  -  serpin peptidase inhibitor, clade b (ovalbumin), member 2, CIDEB  -  cell death-inducing dffa-like effector b]
GO:0052547	regulation of peptidase activity	3E-7	6.92E-4	4.17	10344	229	195	18	[SERPIND1  -  serpin peptidase inhibitor, clade d (heparin cofactor), member 1, SERPINA6  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 6, SERPINA3  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 3, VIL1  -  villin 1, NGF  -  nerve growth factor (beta polypeptide), SPINK6  -  serine peptidase inhibitor, kazal type 6, FABP1  -  fatty acid binding protein 1, liver, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), SPP2  -  secreted phosphoprotein 2, 24kda, TP63  -  tumor protein p63, AHSG  -  alpha-2-hs-glycoprotein, TNF  -  tumor necrosis factor, SERPINB11  -  serpin peptidase inhibitor, clade b (ovalbumin), member 11 (gene/pseudogene), SERPINA11  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 11, AMBP  -  alpha-1-microglobulin/bikunin precursor, SERPINB7  -  serpin peptidase inhibitor, clade b (ovalbumin), member 7, SERPINB2  -  serpin peptidase inhibitor, clade b (ovalbumin), member 2, CIDEB  -  cell death-inducing dffa-like effector b]
GO:0015849	organic acid transport	3.36E-7	6.63E-4	4.64	10344	183	195	16	[PLA2G2F  -  phospholipase a2, group iif, SLC16A12  -  solute carrier family 16, member 12, SLC13A2  -  solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2, LRP2  -  low density lipoprotein receptor-related protein 2, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, FABP1  -  fatty acid binding protein 1, liver, PLA2G2E  -  phospholipase a2, group iie, SLC1A2  -  solute carrier family 1 (glial high affinity glutamate transporter), member 2, SLC7A9  -  solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9, SLC16A4  -  solute carrier family 16, member 4, SLC6A14  -  solute carrier family 6 (amino acid transporter), member 14, ACE2  -  angiotensin i converting enzyme 2, SLC38A8  -  solute carrier family 38, member 8, PLA2G1B  -  phospholipase a2, group ib (pancreas), SLC16A14  -  solute carrier family 16, member 14, SLC36A2  -  solute carrier family 36 (proton/amino acid symporter), member 2]
GO:0046942	carboxylic acid transport	3.36E-7	5.8E-4	4.64	10344	183	195	16	[PLA2G2F  -  phospholipase a2, group iif, SLC16A12  -  solute carrier family 16, member 12, SLC13A2  -  solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2, LRP2  -  low density lipoprotein receptor-related protein 2, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, FABP1  -  fatty acid binding protein 1, liver, PLA2G2E  -  phospholipase a2, group iie, SLC1A2  -  solute carrier family 1 (glial high affinity glutamate transporter), member 2, SLC7A9  -  solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9, SLC16A4  -  solute carrier family 16, member 4, SLC6A14  -  solute carrier family 6 (amino acid transporter), member 14, ACE2  -  angiotensin i converting enzyme 2, SLC38A8  -  solute carrier family 38, member 8, PLA2G1B  -  phospholipase a2, group ib (pancreas), SLC16A14  -  solute carrier family 16, member 14, SLC36A2  -  solute carrier family 36 (proton/amino acid symporter), member 2]
GO:0019433	triglyceride catabolic process	4.33E-7	6.65E-4	18.72	10344	17	195	6	[LIPC  -  lipase, hepatic, APOC3  -  apolipoprotein c-iii, APOA5  -  apolipoprotein a-v, FABP2  -  fatty acid binding protein 2, intestinal, FABP1  -  fatty acid binding protein 1, liver, FABP7  -  fatty acid binding protein 7, brain]
GO:0051346	negative regulation of hydrolase activity	5.66E-7	7.82E-4	4.00	10344	239	195	18	[SERPIND1  -  serpin peptidase inhibitor, clade d (heparin cofactor), member 1, SERPINA6  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 6, SERPINA3  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 3, VIL1  -  villin 1, NGF  -  nerve growth factor (beta polypeptide), PPP1R1C  -  protein phosphatase 1, regulatory (inhibitor) subunit 1c, SPINK6  -  serine peptidase inhibitor, kazal type 6, FABP1  -  fatty acid binding protein 1, liver, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), SPP2  -  secreted phosphoprotein 2, 24kda, AHSG  -  alpha-2-hs-glycoprotein, TNF  -  tumor necrosis factor, SERPINB11  -  serpin peptidase inhibitor, clade b (ovalbumin), member 11 (gene/pseudogene), SERPINA11  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 11, APOC3  -  apolipoprotein c-iii, AMBP  -  alpha-1-microglobulin/bikunin precursor, SERPINB7  -  serpin peptidase inhibitor, clade b (ovalbumin), member 7, SERPINB2  -  serpin peptidase inhibitor, clade b (ovalbumin), member 2]
GO:0044281	small molecule metabolic process	7.3E-7	9.17E-4	2.14	10344	1092	195	44	[ALDH8A1  -  aldehyde dehydrogenase 8 family, member a1, LRP2  -  low density lipoprotein receptor-related protein 2, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), PLCD4  -  phospholipase c, delta 4, MOGAT1  -  monoacylglycerol o-acyltransferase 1, NDST4  -  n-deacetylase/n-sulfotransferase (heparan glucosaminyl) 4, TXNDC8  -  thioredoxin domain containing 8 (spermatozoa), CA1  -  carbonic anhydrase i, CA5A  -  carbonic anhydrase va, mitochondrial, TAT  -  tyrosine aminotransferase, OTC  -  ornithine carbamoyltransferase, LGSN  -  lengsin, lens protein with glutamine synthetase domain, PPARGC1A  -  peroxisome proliferator-activated receptor gamma, coactivator 1 alpha, NPC1L1  -  npc1-like 1, SLC6A14  -  solute carrier family 6 (amino acid transporter), member 14, CA7  -  carbonic anhydrase vii, STAB2  -  stabilin 2, PLA2G1B  -  phospholipase a2, group ib (pancreas), TYR  -  tyrosinase, NME8  -  nme/nm23 family member 8, GCH1  -  gtp cyclohydrolase 1, AFP  -  alpha-fetoprotein, HNF4A  -  hepatocyte nuclear factor 4, alpha, RDH8  -  retinol dehydrogenase 8 (all-trans), APOA5  -  apolipoprotein a-v, GUCA2B  -  guanylate cyclase activator 2b (uroguanylin), PCK1  -  phosphoenolpyruvate carboxykinase 1 (soluble), B4GALNT2  -  beta-1,4-n-acetyl-galactosaminyl transferase 2, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, BHMT  -  betaine--homocysteine s-methyltransferase, MAT1A  -  methionine adenosyltransferase i, alpha, HPD  -  4-hydroxyphenylpyruvate dioxygenase, TNF  -  tumor necrosis factor, LIPC  -  lipase, hepatic, ALDH1B1  -  aldehyde dehydrogenase 1 family, member b1, PAH  -  phenylalanine hydroxylase, GUCY2C  -  guanylate cyclase 2c (heat stable enterotoxin receptor), CYP19A1  -  cytochrome p450, family 19, subfamily a, polypeptide 1, BCMO1  -  beta-carotene 15,15'-monooxygenase 1, CYP26A1  -  cytochrome p450, family 26, subfamily a, polypeptide 1, URAD  -  ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase, MPO  -  myeloperoxidase, BCAT1  -  branched chain amino-acid transaminase 1, cytosolic]
GO:0045861	negative regulation of proteolysis	1.1E-6	1.27E-3	4.52	10344	176	195	15	[SERPIND1  -  serpin peptidase inhibitor, clade d (heparin cofactor), member 1, SERPINA6  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 6, SERPINA3  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 3, VIL1  -  villin 1, NGF  -  nerve growth factor (beta polypeptide), FABP1  -  fatty acid binding protein 1, liver, SPINK6  -  serine peptidase inhibitor, kazal type 6, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), SPP2  -  secreted phosphoprotein 2, 24kda, AHSG  -  alpha-2-hs-glycoprotein, SERPINB11  -  serpin peptidase inhibitor, clade b (ovalbumin), member 11 (gene/pseudogene), SERPINA11  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 11, AMBP  -  alpha-1-microglobulin/bikunin precursor, SERPINB7  -  serpin peptidase inhibitor, clade b (ovalbumin), member 7, SERPINB2  -  serpin peptidase inhibitor, clade b (ovalbumin), member 2]
GO:0006641	triglyceride metabolic process	1.64E-6	1.74E-3	9.43	10344	45	195	8	[APOC3  -  apolipoprotein c-iii, LIPC  -  lipase, hepatic, APOA5  -  apolipoprotein a-v, FABP2  -  fatty acid binding protein 2, intestinal, FABP1  -  fatty acid binding protein 1, liver, MOGAT1  -  monoacylglycerol o-acyltransferase 1, CAV3  -  caveolin 3, FABP7  -  fatty acid binding protein 7, brain]
GO:0046461	neutral lipid catabolic process	3.21E-6	3.17E-3	13.84	10344	23	195	6	[LIPC  -  lipase, hepatic, APOC3  -  apolipoprotein c-iii, APOA5  -  apolipoprotein a-v, FABP2  -  fatty acid binding protein 2, intestinal, FABP1  -  fatty acid binding protein 1, liver, FABP7  -  fatty acid binding protein 7, brain]
GO:0046464	acylglycerol catabolic process	3.21E-6	2.96E-3	13.84	10344	23	195	6	[APOC3  -  apolipoprotein c-iii, LIPC  -  lipase, hepatic, APOA5  -  apolipoprotein a-v, FABP2  -  fatty acid binding protein 2, intestinal, FABP1  -  fatty acid binding protein 1, liver, FABP7  -  fatty acid binding protein 7, brain]
GO:0042445	hormone metabolic process	8.05E-6	6.96E-3	5.21	10344	112	195	11	[SERPINA6  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 6, CRHBP  -  corticotropin releasing hormone binding protein, RDH8  -  retinol dehydrogenase 8 (all-trans), PPARGC1A  -  peroxisome proliferator-activated receptor gamma, coactivator 1 alpha, NGF  -  nerve growth factor (beta polypeptide), ACE2  -  angiotensin i converting enzyme 2, ALDH8A1  -  aldehyde dehydrogenase 8 family, member a1, CYP19A1  -  cytochrome p450, family 19, subfamily a, polypeptide 1, BCMO1  -  beta-carotene 15,15'-monooxygenase 1, AFP  -  alpha-fetoprotein, CYP26A1  -  cytochrome p450, family 26, subfamily a, polypeptide 1]
GO:0006629	lipid metabolic process	8.75E-6	7.12E-3	2.24	10344	781	195	33	[MTTP  -  microsomal triglyceride transfer protein, PLA2G2F  -  phospholipase a2, group iif, KLB  -  klotho beta, ALDH8A1  -  aldehyde dehydrogenase 8 family, member a1, FABP2  -  fatty acid binding protein 2, intestinal, LRP2  -  low density lipoprotein receptor-related protein 2, FABP1  -  fatty acid binding protein 1, liver, MOGAT1  -  monoacylglycerol o-acyltransferase 1, PLCD4  -  phospholipase c, delta 4, FABP7  -  fatty acid binding protein 7, brain, PPARGC1A  -  peroxisome proliferator-activated receptor gamma, coactivator 1 alpha, NPC1L1  -  npc1-like 1, PLA2G1B  -  phospholipase a2, group ib (pancreas), AFP  -  alpha-fetoprotein, HNF4A  -  hepatocyte nuclear factor 4, alpha, SERPINA6  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 6, RDH8  -  retinol dehydrogenase 8 (all-trans), APOA5  -  apolipoprotein a-v, ST8SIA6  -  st8 alpha-n-acetyl-neuraminide alpha-2,8-sialyltransferase 6, PCK1  -  phosphoenolpyruvate carboxykinase 1 (soluble), NR0B1  -  nuclear receptor subfamily 0, group b, member 1, B4GALNT2  -  beta-1,4-n-acetyl-galactosaminyl transferase 2, PLA2G2E  -  phospholipase a2, group iie, CERS3  -  ceramide synthase 3, CAV3  -  caveolin 3, ETNPPL  -  ethanolamine-phosphate phospho-lyase, APOC3  -  apolipoprotein c-iii, LIPC  -  lipase, hepatic, BCMO1  -  beta-carotene 15,15'-monooxygenase 1, CYP19A1  -  cytochrome p450, family 19, subfamily a, polypeptide 1, NR1I2  -  nuclear receptor subfamily 1, group i, member 2, ST8SIA2  -  st8 alpha-n-acetyl-neuraminide alpha-2,8-sialyltransferase 2, CYP26A1  -  cytochrome p450, family 26, subfamily a, polypeptide 1]
GO:0006811	ion transport	8.97E-6	6.89E-3	2.17	10344	855	195	35	[MTTP  -  microsomal triglyceride transfer protein, PLA2G2F  -  phospholipase a2, group iif, SLC13A2  -  solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2, LRP2  -  low density lipoprotein receptor-related protein 2, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, FABP1  -  fatty acid binding protein 1, liver, CA1  -  carbonic anhydrase i, CA5A  -  carbonic anhydrase va, mitochondrial, SLC16A4  -  solute carrier family 16, member 4, SLC12A1  -  solute carrier family 12 (sodium/potassium/chloride transporter), member 1, CA7  -  carbonic anhydrase vii, SLC6A14  -  solute carrier family 6 (amino acid transporter), member 14, ACE2  -  angiotensin i converting enzyme 2, SLC9A2  -  solute carrier family 9, subfamily a (nhe2, cation proton antiporter 2), member 2, PLA2G1B  -  phospholipase a2, group ib (pancreas), HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, SLC36A2  -  solute carrier family 36 (proton/amino acid symporter), member 2, APOA5  -  apolipoprotein a-v, SLC16A12  -  solute carrier family 16, member 12, KCNJ16  -  potassium inwardly-rectifying channel, subfamily j, member 16, SLC30A2  -  solute carrier family 30 (zinc transporter), member 2, PLA2G2E  -  phospholipase a2, group iie, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, SLC1A2  -  solute carrier family 1 (glial high affinity glutamate transporter), member 2, SLC7A9  -  solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9, AQP8  -  aquaporin 8, APOC3  -  apolipoprotein c-iii, SLC4A1  -  solute carrier family 4 (anion exchanger), member 1, KCNJ1  -  potassium inwardly-rectifying channel, subfamily j, member 1, SLC38A8  -  solute carrier family 38, member 8, SLC16A14  -  solute carrier family 16, member 14, ATP2B3  -  atpase, ca++ transporting, plasma membrane 3, TRPV5  -  transient receptor potential cation channel, subfamily v, member 5, SLC5A1  -  solute carrier family 5 (sodium/glucose cotransporter), member 1, ATP13A4  -  atpase type 13a4]
GO:0006638	neutral lipid metabolic process	1.03E-5	7.53E-3	7.45	10344	57	195	8	[APOA5  -  apolipoprotein a-v, LIPC  -  lipase, hepatic, APOC3  -  apolipoprotein c-iii, FABP2  -  fatty acid binding protein 2, intestinal, FABP1  -  fatty acid binding protein 1, liver, MOGAT1  -  monoacylglycerol o-acyltransferase 1, CAV3  -  caveolin 3, FABP7  -  fatty acid binding protein 7, brain]
GO:0006639	acylglycerol metabolic process	1.03E-5	7.16E-3	7.45	10344	57	195	8	[APOA5  -  apolipoprotein a-v, APOC3  -  apolipoprotein c-iii, LIPC  -  lipase, hepatic, FABP2  -  fatty acid binding protein 2, intestinal, FABP1  -  fatty acid binding protein 1, liver, MOGAT1  -  monoacylglycerol o-acyltransferase 1, CAV3  -  caveolin 3, FABP7  -  fatty acid binding protein 7, brain]
GO:0065008	regulation of biological quality	1.04E-5	6.85E-3	1.62	10344	2226	195	68	[F13B  -  coagulation factor xiii, b polypeptide, SERPINA3  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 3, FAM19A4  -  family with sequence similarity 19 (chemokine (c-c motif)-like), member a4, TAC1  -  tachykinin, precursor 1, PLXNC1  -  plexin c1, AHSP  -  alpha hemoglobin stabilizing protein, PTPRN  -  protein tyrosine phosphatase, receptor type, n, SLC12A1  -  solute carrier family 12 (sodium/potassium/chloride transporter), member 1, KEL  -  kell blood group, metallo-endopeptidase, OTC  -  ornithine carbamoyltransferase, ACE2  -  angiotensin i converting enzyme 2, SLC9A2  -  solute carrier family 9, subfamily a (nhe2, cation proton antiporter 2), member 2, NME8  -  nme/nm23 family member 8, GCH1  -  gtp cyclohydrolase 1, LMOD3  -  leiomodin 3 (fetal), AFP  -  alpha-fetoprotein, IGF2BP3  -  insulin-like growth factor 2 mrna binding protein 3, IGF2BP1  -  insulin-like growth factor 2 mrna binding protein 1, GUCA2B  -  guanylate cyclase activator 2b (uroguanylin), VIL1  -  villin 1, NGF  -  nerve growth factor (beta polypeptide), BHMT  -  betaine--homocysteine s-methyltransferase, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, SLC1A2  -  solute carrier family 1 (glial high affinity glutamate transporter), member 2, HIST1H4L  -  histone cluster 1, h4l, CRHBP  -  corticotropin releasing hormone binding protein, TNF  -  tumor necrosis factor, MYL4  -  myosin, light chain 4, alkali; atrial, embryonic, LIPC  -  lipase, hepatic, APOC3  -  apolipoprotein c-iii, SLC4A1  -  solute carrier family 4 (anion exchanger), member 1, PAH  -  phenylalanine hydroxylase, SERPINB2  -  serpin peptidase inhibitor, clade b (ovalbumin), member 2, ATP2B3  -  atpase, ca++ transporting, plasma membrane 3, NR1I2  -  nuclear receptor subfamily 1, group i, member 2, F5  -  coagulation factor v (proaccelerin, labile factor), F7  -  coagulation factor vii (serum prothrombin conversion accelerator), ATP13A4  -  atpase type 13a4, ALDH8A1  -  aldehyde dehydrogenase 8 family, member a1, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, AVIL  -  advillin, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), ACTN2  -  actinin, alpha 2, TXNDC8  -  thioredoxin domain containing 8 (spermatozoa), PROC  -  protein c (inactivator of coagulation factors va and viiia), PPARGC1A  -  peroxisome proliferator-activated receptor gamma, coactivator 1 alpha, CA7  -  carbonic anhydrase vii, FGB  -  fibrinogen beta chain, PLA2G1B  -  phospholipase a2, group ib (pancreas), HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, TNFRSF13B  -  tumor necrosis factor receptor superfamily, member 13b, HNF4A  -  hepatocyte nuclear factor 4, alpha, SERPIND1  -  serpin peptidase inhibitor, clade d (heparin cofactor), member 1, SERPINA6  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 6, RDH8  -  retinol dehydrogenase 8 (all-trans), APOA5  -  apolipoprotein a-v, CSF3  -  colony stimulating factor 3 (granulocyte), PCK1  -  phosphoenolpyruvate carboxykinase 1 (soluble), EPB42  -  erythrocyte membrane protein band 4.2, SLC30A2  -  solute carrier family 30 (zinc transporter), member 2, TP63  -  tumor protein p63, CAV3  -  caveolin 3, SEZ6  -  seizure related 6 homolog (mouse), PRKCQ  -  protein kinase c, theta, BCMO1  -  beta-carotene 15,15'-monooxygenase 1, CYP19A1  -  cytochrome p450, family 19, subfamily a, polypeptide 1, TRPV5  -  transient receptor potential cation channel, subfamily v, member 5, CYP26A1  -  cytochrome p450, family 26, subfamily a, polypeptide 1]
GO:0071827	plasma lipoprotein particle organization	1.38E-5	8.64E-3	10.98	10344	29	195	6	[APOC3  -  apolipoprotein c-iii, LIPC  -  lipase, hepatic, APOA5  -  apolipoprotein a-v, MTTP  -  microsomal triglyceride transfer protein, PLA2G2E  -  phospholipase a2, group iie, MPO  -  myeloperoxidase]
GO:0071825	protein-lipid complex subunit organization	1.69E-5	1.02E-2	10.61	10344	30	195	6	[LIPC  -  lipase, hepatic, APOC3  -  apolipoprotein c-iii, APOA5  -  apolipoprotein a-v, MTTP  -  microsomal triglyceride transfer protein, PLA2G2E  -  phospholipase a2, group iie, MPO  -  myeloperoxidase]
GO:0010817	regulation of hormone levels	1.95E-5	1.13E-2	2.99	10344	337	195	19	[HNF4A  -  hepatocyte nuclear factor 4, alpha, SERPINA6  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 6, RDH8  -  retinol dehydrogenase 8 (all-trans), NGF  -  nerve growth factor (beta polypeptide), TAC1  -  tachykinin, precursor 1, ALDH8A1  -  aldehyde dehydrogenase 8 family, member a1, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), PTPRN  -  protein tyrosine phosphatase, receptor type, n, TNF  -  tumor necrosis factor, CRHBP  -  corticotropin releasing hormone binding protein, PPARGC1A  -  peroxisome proliferator-activated receptor gamma, coactivator 1 alpha, FGB  -  fibrinogen beta chain, ACE2  -  angiotensin i converting enzyme 2, CYP19A1  -  cytochrome p450, family 19, subfamily a, polypeptide 1, BCMO1  -  beta-carotene 15,15'-monooxygenase 1, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, AFP  -  alpha-fetoprotein, CYP26A1  -  cytochrome p450, family 26, subfamily a, polypeptide 1]
GO:0032501	multicellular organismal process	2.24E-5	1.24E-2	1.62	10344	2096	195	64	[GCM1  -  glial cells missing homolog 1 (drosophila), MTTP  -  microsomal triglyceride transfer protein, PAX1  -  paired box 1, F13B  -  coagulation factor xiii, b polypeptide, SERPINA3  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 3, TAC1  -  tachykinin, precursor 1, FABP2  -  fatty acid binding protein 2, intestinal, FABP1  -  fatty acid binding protein 1, liver, SPP2  -  secreted phosphoprotein 2, 24kda, KEL  -  kell blood group, metallo-endopeptidase, ACE2  -  angiotensin i converting enzyme 2, NME8  -  nme/nm23 family member 8, GCH1  -  gtp cyclohydrolase 1, LMOD3  -  leiomodin 3 (fetal), UPK2  -  uroplakin 2, IGF2BP1  -  insulin-like growth factor 2 mrna binding protein 1, GUCA2B  -  guanylate cyclase activator 2b (uroguanylin), VIL1  -  villin 1, NGF  -  nerve growth factor (beta polypeptide), TBX20  -  t-box 20, PLA2G2E  -  phospholipase a2, group iie, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, SLC1A2  -  solute carrier family 1 (glial high affinity glutamate transporter), member 2, AHSG  -  alpha-2-hs-glycoprotein, CRHBP  -  corticotropin releasing hormone binding protein, MYL4  -  myosin, light chain 4, alkali; atrial, embryonic, LIPC  -  lipase, hepatic, APOC3  -  apolipoprotein c-iii, DSG3  -  desmoglein 3, GUCY2C  -  guanylate cyclase 2c (heat stable enterotoxin receptor), ACTC1  -  actin, alpha, cardiac muscle 1, NR1I2  -  nuclear receptor subfamily 1, group i, member 2, SLC5A1  -  solute carrier family 5 (sodium/glucose cotransporter), member 1, F5  -  coagulation factor v (proaccelerin, labile factor), F7  -  coagulation factor vii (serum prothrombin conversion accelerator), PITX2  -  paired-like homeodomain 2, LRP2  -  low density lipoprotein receptor-related protein 2, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), TXNDC8  -  thioredoxin domain containing 8 (spermatozoa), PROC  -  protein c (inactivator of coagulation factors va and viiia), TMPRSS11E  -  transmembrane protease, serine 11e, PPARGC1A  -  peroxisome proliferator-activated receptor gamma, coactivator 1 alpha, NPC1L1  -  npc1-like 1, AMBP  -  alpha-1-microglobulin/bikunin precursor, FGB  -  fibrinogen beta chain, CDX2  -  caudal type homeobox 2, PLA2G1B  -  phospholipase a2, group ib (pancreas), PKP1  -  plakophilin 1 (ectodermal dysplasia/skin fragility syndrome), TYR  -  tyrosinase, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, HNF4A  -  hepatocyte nuclear factor 4, alpha, SERPIND1  -  serpin peptidase inhibitor, clade d (heparin cofactor), member 1, RDH8  -  retinol dehydrogenase 8 (all-trans), APOA5  -  apolipoprotein a-v, CSF3  -  colony stimulating factor 3 (granulocyte), TP63  -  tumor protein p63, SEZ6  -  seizure related 6 homolog (mouse), CAV3  -  caveolin 3, KCNJ1  -  potassium inwardly-rectifying channel, subfamily j, member 1, CYP19A1  -  cytochrome p450, family 19, subfamily a, polypeptide 1, PDE6C  -  phosphodiesterase 6c, cgmp-specific, cone, alpha prime, TRPV5  -  transient receptor potential cation channel, subfamily v, member 5, MPO  -  myeloperoxidase]
GO:0008202	steroid metabolic process	3.54E-5	1.88E-2	4.11	10344	155	195	12	[SERPINA6  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 6, RDH8  -  retinol dehydrogenase 8 (all-trans), APOA5  -  apolipoprotein a-v, PPARGC1A  -  peroxisome proliferator-activated receptor gamma, coactivator 1 alpha, LIPC  -  lipase, hepatic, NPC1L1  -  npc1-like 1, LRP2  -  low density lipoprotein receptor-related protein 2, NR0B1  -  nuclear receptor subfamily 0, group b, member 1, CYP19A1  -  cytochrome p450, family 19, subfamily a, polypeptide 1, NR1I2  -  nuclear receptor subfamily 1, group i, member 2, AFP  -  alpha-fetoprotein, CYP26A1  -  cytochrome p450, family 26, subfamily a, polypeptide 1]
GO:0046503	glycerolipid catabolic process	3.6E-5	1.84E-2	9.36	10344	34	195	6	[APOC3  -  apolipoprotein c-iii, LIPC  -  lipase, hepatic, APOA5  -  apolipoprotein a-v, FABP2  -  fatty acid binding protein 2, intestinal, FABP1  -  fatty acid binding protein 1, liver, FABP7  -  fatty acid binding protein 7, brain]
GO:0034368	protein-lipid complex remodeling	3.6E-5	1.78E-2	12.63	10344	21	195	5	[LIPC  -  lipase, hepatic, APOC3  -  apolipoprotein c-iii, APOA5  -  apolipoprotein a-v, PLA2G2E  -  phospholipase a2, group iie, MPO  -  myeloperoxidase]
GO:0034369	plasma lipoprotein particle remodeling	3.6E-5	1.72E-2	12.63	10344	21	195	5	[APOC3  -  apolipoprotein c-iii, LIPC  -  lipase, hepatic, APOA5  -  apolipoprotein a-v, PLA2G2E  -  phospholipase a2, group iie, MPO  -  myeloperoxidase]
GO:0050892	intestinal absorption	3.6E-5	1.66E-2	12.63	10344	21	195	5	[NPC1L1  -  npc1-like 1, VIL1  -  villin 1, FABP2  -  fatty acid binding protein 2, intestinal, FABP1  -  fatty acid binding protein 1, liver, SLC5A1  -  solute carrier family 5 (sodium/glucose cotransporter), member 1]
GO:0034367	protein-containing complex remodeling	4.59E-5	2.05E-2	12.06	10344	22	195	5	[APOC3  -  apolipoprotein c-iii, LIPC  -  lipase, hepatic, APOA5  -  apolipoprotein a-v, PLA2G2E  -  phospholipase a2, group iie, MPO  -  myeloperoxidase]
GO:0006869	lipid transport	7.34E-5	3.17E-2	3.81	10344	167	195	12	[MTTP  -  microsomal triglyceride transfer protein, APOA5  -  apolipoprotein a-v, APOC3  -  apolipoprotein c-iii, LIPC  -  lipase, hepatic, NPC1L1  -  npc1-like 1, PLA2G2F  -  phospholipase a2, group iif, PLA2G1B  -  phospholipase a2, group ib (pancreas), FABP2  -  fatty acid binding protein 2, intestinal, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, FABP1  -  fatty acid binding protein 1, liver, PLA2G2E  -  phospholipase a2, group iie, CAV3  -  caveolin 3]
GO:0034754	cellular hormone metabolic process	1.01E-4	4.24E-2	6.40	10344	58	195	7	[RDH8  -  retinol dehydrogenase 8 (all-trans), PPARGC1A  -  peroxisome proliferator-activated receptor gamma, coactivator 1 alpha, ALDH8A1  -  aldehyde dehydrogenase 8 family, member a1, CYP19A1  -  cytochrome p450, family 19, subfamily a, polypeptide 1, BCMO1  -  beta-carotene 15,15'-monooxygenase 1, AFP  -  alpha-fetoprotein, CYP26A1  -  cytochrome p450, family 26, subfamily a, polypeptide 1]
GO:0016042	lipid catabolic process	1.43E-4	5.8E-2	3.56	10344	179	195	12	[APOA5  -  apolipoprotein a-v, APOC3  -  apolipoprotein c-iii, LIPC  -  lipase, hepatic, PLA2G2F  -  phospholipase a2, group iif, PCK1  -  phosphoenolpyruvate carboxykinase 1 (soluble), FABP2  -  fatty acid binding protein 2, intestinal, FABP1  -  fatty acid binding protein 1, liver, CYP19A1  -  cytochrome p450, family 19, subfamily a, polypeptide 1, PLCD4  -  phospholipase c, delta 4, PLA2G2E  -  phospholipase a2, group iie, FABP7  -  fatty acid binding protein 7, brain, CYP26A1  -  cytochrome p450, family 26, subfamily a, polypeptide 1]
GO:0050878	regulation of body fluid levels	1.77E-4	6.98E-2	3.09	10344	240	195	14	[HNF4A  -  hepatocyte nuclear factor 4, alpha, SERPIND1  -  serpin peptidase inhibitor, clade d (heparin cofactor), member 1, GUCA2B  -  guanylate cyclase activator 2b (uroguanylin), F13B  -  coagulation factor xiii, b polypeptide, TAC1  -  tachykinin, precursor 1, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), TP63  -  tumor protein p63, PROC  -  protein c (inactivator of coagulation factors va and viiia), PRKCQ  -  protein kinase c, theta, FGB  -  fibrinogen beta chain, SERPINB2  -  serpin peptidase inhibitor, clade b (ovalbumin), member 2, TRPV5  -  transient receptor potential cation channel, subfamily v, member 5, F5  -  coagulation factor v (proaccelerin, labile factor), F7  -  coagulation factor vii (serum prothrombin conversion accelerator)]
GO:0015718	monocarboxylic acid transport	2.09E-4	8.01E-2	4.93	10344	86	195	8	[SLC16A4  -  solute carrier family 16, member 4, PLA2G2F  -  phospholipase a2, group iif, SLC16A12  -  solute carrier family 16, member 12, PLA2G1B  -  phospholipase a2, group ib (pancreas), ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, SLC16A14  -  solute carrier family 16, member 14, FABP1  -  fatty acid binding protein 1, liver, PLA2G2E  -  phospholipase a2, group iie]
GO:0048878	chemical homeostasis	2.24E-4	8.37E-2	2.12	10344	652	195	26	[TAC1  -  tachykinin, precursor 1, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), SLC12A1  -  solute carrier family 12 (sodium/potassium/chloride transporter), member 1, KEL  -  kell blood group, metallo-endopeptidase, PPARGC1A  -  peroxisome proliferator-activated receptor gamma, coactivator 1 alpha, OTC  -  ornithine carbamoyltransferase, CA7  -  carbonic anhydrase vii, SLC9A2  -  solute carrier family 9, subfamily a (nhe2, cation proton antiporter 2), member 2, PLA2G1B  -  phospholipase a2, group ib (pancreas), HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, HNF4A  -  hepatocyte nuclear factor 4, alpha, APOA5  -  apolipoprotein a-v, PCK1  -  phosphoenolpyruvate carboxykinase 1 (soluble), EPB42  -  erythrocyte membrane protein band 4.2, SLC30A2  -  solute carrier family 30 (zinc transporter), member 2, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, TP63  -  tumor protein p63, CAV3  -  caveolin 3, APOC3  -  apolipoprotein c-iii, LIPC  -  lipase, hepatic, SLC4A1  -  solute carrier family 4 (anion exchanger), member 1, ATP2B3  -  atpase, ca++ transporting, plasma membrane 3, NR1I2  -  nuclear receptor subfamily 1, group i, member 2, TRPV5  -  transient receptor potential cation channel, subfamily v, member 5, ATP13A4  -  atpase type 13a4]
GO:0042737	drug catabolic process	2.31E-4	8.41E-2	5.63	10344	66	195	7	[TAT  -  tyrosine aminotransferase, ALDH1B1  -  aldehyde dehydrogenase 1 family, member b1, PCK1  -  phosphoenolpyruvate carboxykinase 1 (soluble), PAH  -  phenylalanine hydroxylase, NR1I2  -  nuclear receptor subfamily 1, group i, member 2, MPO  -  myeloperoxidase, HPD  -  4-hydroxyphenylpyruvate dioxygenase]
GO:0022600	digestive system process	2.34E-4	8.32E-2	6.77	10344	47	195	6	[NPC1L1  -  npc1-like 1, VIL1  -  villin 1, SERPINA3  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 3, FABP2  -  fatty acid binding protein 2, intestinal, FABP1  -  fatty acid binding protein 1, liver, SLC5A1  -  solute carrier family 5 (sodium/glucose cotransporter), member 1]
GO:1901615	organic hydroxy compound metabolic process	2.35E-4	8.11E-2	2.87	10344	277	195	15	[RDH8  -  retinol dehydrogenase 8 (all-trans), APOA5  -  apolipoprotein a-v, PCK1  -  phosphoenolpyruvate carboxykinase 1 (soluble), LRP2  -  low density lipoprotein receptor-related protein 2, MOGAT1  -  monoacylglycerol o-acyltransferase 1, PLCD4  -  phospholipase c, delta 4, LIPC  -  lipase, hepatic, ALDH1B1  -  aldehyde dehydrogenase 1 family, member b1, NPC1L1  -  npc1-like 1, PAH  -  phenylalanine hydroxylase, TYR  -  tyrosinase, BCMO1  -  beta-carotene 15,15'-monooxygenase 1, CYP19A1  -  cytochrome p450, family 19, subfamily a, polypeptide 1, GCH1  -  gtp cyclohydrolase 1, CYP26A1  -  cytochrome p450, family 26, subfamily a, polypeptide 1]
GO:0055090	acylglycerol homeostasis	2.4E-4	8.11E-2	12.48	10344	17	195	4	[HNF4A  -  hepatocyte nuclear factor 4, alpha, LIPC  -  lipase, hepatic, APOC3  -  apolipoprotein c-iii, APOA5  -  apolipoprotein a-v]
GO:0070328	triglyceride homeostasis	2.4E-4	7.92E-2	12.48	10344	17	195	4	[HNF4A  -  hepatocyte nuclear factor 4, alpha, LIPC  -  lipase, hepatic, APOC3  -  apolipoprotein c-iii, APOA5  -  apolipoprotein a-v]
GO:0001523	retinoid metabolic process	2.96E-4	9.52E-2	6.50	10344	49	195	6	[RDH8  -  retinol dehydrogenase 8 (all-trans), APOC3  -  apolipoprotein c-iii, ALDH8A1  -  aldehyde dehydrogenase 8 family, member a1, LRP2  -  low density lipoprotein receptor-related protein 2, BCMO1  -  beta-carotene 15,15'-monooxygenase 1, CYP26A1  -  cytochrome p450, family 26, subfamily a, polypeptide 1]
GO:0044255	cellular lipid metabolic process	3.29E-4	1.03E-1	2.10	10344	631	195	25	[PLA2G2F  -  phospholipase a2, group iif, ALDH8A1  -  aldehyde dehydrogenase 8 family, member a1, KLB  -  klotho beta, FABP2  -  fatty acid binding protein 2, intestinal, LRP2  -  low density lipoprotein receptor-related protein 2, FABP1  -  fatty acid binding protein 1, liver, PLCD4  -  phospholipase c, delta 4, MOGAT1  -  monoacylglycerol o-acyltransferase 1, FABP7  -  fatty acid binding protein 7, brain, PPARGC1A  -  peroxisome proliferator-activated receptor gamma, coactivator 1 alpha, PLA2G1B  -  phospholipase a2, group ib (pancreas), APOA5  -  apolipoprotein a-v, RDH8  -  retinol dehydrogenase 8 (all-trans), ST8SIA6  -  st8 alpha-n-acetyl-neuraminide alpha-2,8-sialyltransferase 6, PCK1  -  phosphoenolpyruvate carboxykinase 1 (soluble), B4GALNT2  -  beta-1,4-n-acetyl-galactosaminyl transferase 2, CERS3  -  ceramide synthase 3, PLA2G2E  -  phospholipase a2, group iie, CAV3  -  caveolin 3, ETNPPL  -  ethanolamine-phosphate phospho-lyase, APOC3  -  apolipoprotein c-iii, LIPC  -  lipase, hepatic, BCMO1  -  beta-carotene 15,15'-monooxygenase 1, ST8SIA2  -  st8 alpha-n-acetyl-neuraminide alpha-2,8-sialyltransferase 2, CYP26A1  -  cytochrome p450, family 26, subfamily a, polypeptide 1]
GO:0032269	negative regulation of cellular protein metabolic process	3.44E-4	1.06E-1	2.14	10344	596	195	24	[SERPIND1  -  serpin peptidase inhibitor, clade d (heparin cofactor), member 1, SERPINA6  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 6, IGF2BP3  -  insulin-like growth factor 2 mrna binding protein 3, IGF2BP1  -  insulin-like growth factor 2 mrna binding protein 1, SERPINA3  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 3, VIL1  -  villin 1, NGF  -  nerve growth factor (beta polypeptide), RPS6KA6  -  ribosomal protein s6 kinase, 90kda, polypeptide 6, PPP1R1C  -  protein phosphatase 1, regulatory (inhibitor) subunit 1c, RNF222  -  ring finger protein 222, SPINK6  -  serine peptidase inhibitor, kazal type 6, FABP1  -  fatty acid binding protein 1, liver, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), SPP2  -  secreted phosphoprotein 2, 24kda, CAV3  -  caveolin 3, AHSG  -  alpha-2-hs-glycoprotein, TNF  -  tumor necrosis factor, PPARGC1A  -  peroxisome proliferator-activated receptor gamma, coactivator 1 alpha, SERPINA11  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 11, SERPINB11  -  serpin peptidase inhibitor, clade b (ovalbumin), member 11 (gene/pseudogene), AMBP  -  alpha-1-microglobulin/bikunin precursor, LMO3  -  lim domain only 3 (rhombotin-like 2), SERPINB7  -  serpin peptidase inhibitor, clade b (ovalbumin), member 7, SERPINB2  -  serpin peptidase inhibitor, clade b (ovalbumin), member 2]
GO:0006558	L-phenylalanine metabolic process	3.45E-4	1.04E-1	19.89	10344	8	195	3	[TAT  -  tyrosine aminotransferase, PAH  -  phenylalanine hydroxylase, HPD  -  4-hydroxyphenylpyruvate dioxygenase]
GO:0006559	L-phenylalanine catabolic process	3.45E-4	1.01E-1	19.89	10344	8	195	3	[TAT  -  tyrosine aminotransferase, PAH  -  phenylalanine hydroxylase, HPD  -  4-hydroxyphenylpyruvate dioxygenase]
GO:0034370	triglyceride-rich lipoprotein particle remodeling	3.45E-4	9.93E-2	19.89	10344	8	195	3	[LIPC  -  lipase, hepatic, APOA5  -  apolipoprotein a-v, APOC3  -  apolipoprotein c-iii]
GO:0034374	low-density lipoprotein particle remodeling	3.45E-4	9.72E-2	19.89	10344	8	195	3	[LIPC  -  lipase, hepatic, PLA2G2E  -  phospholipase a2, group iie, MPO  -  myeloperoxidase]
GO:1902221	erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process	3.45E-4	9.53E-2	19.89	10344	8	195	3	[TAT  -  tyrosine aminotransferase, PAH  -  phenylalanine hydroxylase, HPD  -  4-hydroxyphenylpyruvate dioxygenase]
GO:1902222	erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process	3.45E-4	9.34E-2	19.89	10344	8	195	3	[TAT  -  tyrosine aminotransferase, PAH  -  phenylalanine hydroxylase, HPD  -  4-hydroxyphenylpyruvate dioxygenase]
GO:0036149	phosphatidylinositol acyl-chain remodeling	3.45E-4	9.16E-2	19.89	10344	8	195	3	[PLA2G2F  -  phospholipase a2, group iif, PLA2G1B  -  phospholipase a2, group ib (pancreas), PLA2G2E  -  phospholipase a2, group iie]
GO:0030162	regulation of proteolysis	3.5E-4	9.12E-2	2.41	10344	419	195	19	[SERPIND1  -  serpin peptidase inhibitor, clade d (heparin cofactor), member 1, SERPINA6  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 6, SERPINA3  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 3, VIL1  -  villin 1, NGF  -  nerve growth factor (beta polypeptide), SPINK6  -  serine peptidase inhibitor, kazal type 6, FABP1  -  fatty acid binding protein 1, liver, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), TP63  -  tumor protein p63, SPP2  -  secreted phosphoprotein 2, 24kda, AHSG  -  alpha-2-hs-glycoprotein, CAV3  -  caveolin 3, TNF  -  tumor necrosis factor, SERPINA11  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 11, SERPINB11  -  serpin peptidase inhibitor, clade b (ovalbumin), member 11 (gene/pseudogene), AMBP  -  alpha-1-microglobulin/bikunin precursor, SERPINB7  -  serpin peptidase inhibitor, clade b (ovalbumin), member 7, SERPINB2  -  serpin peptidase inhibitor, clade b (ovalbumin), member 2, CIDEB  -  cell death-inducing dffa-like effector b]
GO:0071332	cellular response to fructose stimulus	3.54E-4	9.06E-2	53.05	10344	2	195	2	[PPARGC1A  -  peroxisome proliferator-activated receptor gamma, coactivator 1 alpha, PCK1  -  phosphoenolpyruvate carboxykinase 1 (soluble)]
GO:1904640	response to methionine	3.54E-4	8.89E-2	53.05	10344	2	195	2	[PPARGC1A  -  peroxisome proliferator-activated receptor gamma, coactivator 1 alpha, PCK1  -  phosphoenolpyruvate carboxykinase 1 (soluble)]
GO:0097272	ammonia homeostasis	3.54E-4	8.73E-2	53.05	10344	2	195	2	[OTC  -  ornithine carbamoyltransferase, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta)]
GO:0060577	pulmonary vein morphogenesis	3.54E-4	8.58E-2	53.05	10344	2	195	2	[PITX2  -  paired-like homeodomain 2, TBX20  -  t-box 20]
GO:0071715	icosanoid transport	3.8E-4	9.06E-2	11.17	10344	19	195	4	[PLA2G2F  -  phospholipase a2, group iif, PLA2G1B  -  phospholipase a2, group ib (pancreas), ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, PLA2G2E  -  phospholipase a2, group iie]
GO:1901571	fatty acid derivative transport	3.8E-4	8.91E-2	11.17	10344	19	195	4	[PLA2G2F  -  phospholipase a2, group iif, PLA2G1B  -  phospholipase a2, group ib (pancreas), ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, PLA2G2E  -  phospholipase a2, group iie]
GO:1901605	alpha-amino acid metabolic process	4.09E-4	9.43E-2	3.66	10344	145	195	10	[HNF4A  -  hepatocyte nuclear factor 4, alpha, LGSN  -  lengsin, lens protein with glutamine synthetase domain, TAT  -  tyrosine aminotransferase, OTC  -  ornithine carbamoyltransferase, PAH  -  phenylalanine hydroxylase, TYR  -  tyrosinase, BHMT  -  betaine--homocysteine s-methyltransferase, MAT1A  -  methionine adenosyltransferase i, alpha, BCAT1  -  branched chain amino-acid transaminase 1, cytosolic, HPD  -  4-hydroxyphenylpyruvate dioxygenase]
GO:0003008	system process	4.4E-4	9.98E-2	1.88	10344	875	195	31	[SERPINA3  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 3, TAC1  -  tachykinin, precursor 1, LRP2  -  low density lipoprotein receptor-related protein 2, FABP2  -  fatty acid binding protein 2, intestinal, FABP1  -  fatty acid binding protein 1, liver, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), TMPRSS11E  -  transmembrane protease, serine 11e, KEL  -  kell blood group, metallo-endopeptidase, PPARGC1A  -  peroxisome proliferator-activated receptor gamma, coactivator 1 alpha, NPC1L1  -  npc1-like 1, FGB  -  fibrinogen beta chain, ACE2  -  angiotensin i converting enzyme 2, TYR  -  tyrosinase, GCH1  -  gtp cyclohydrolase 1, LMOD3  -  leiomodin 3 (fetal), HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, RDH8  -  retinol dehydrogenase 8 (all-trans), GUCA2B  -  guanylate cyclase activator 2b (uroguanylin), VIL1  -  villin 1, NGF  -  nerve growth factor (beta polypeptide), TBX20  -  t-box 20, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, CAV3  -  caveolin 3, CRHBP  -  corticotropin releasing hormone binding protein, MYL4  -  myosin, light chain 4, alkali; atrial, embryonic, KCNJ1  -  potassium inwardly-rectifying channel, subfamily j, member 1, ACTC1  -  actin, alpha, cardiac muscle 1, PDE6C  -  phosphodiesterase 6c, cgmp-specific, cone, alpha prime, TRPV5  -  transient receptor potential cation channel, subfamily v, member 5, SLC5A1  -  solute carrier family 5 (sodium/glucose cotransporter), member 1, F5  -  coagulation factor v (proaccelerin, labile factor)]
GO:0016101	diterpenoid metabolic process	4.57E-4	1.02E-1	6.01	10344	53	195	6	[RDH8  -  retinol dehydrogenase 8 (all-trans), APOC3  -  apolipoprotein c-iii, ALDH8A1  -  aldehyde dehydrogenase 8 family, member a1, LRP2  -  low density lipoprotein receptor-related protein 2, BCMO1  -  beta-carotene 15,15'-monooxygenase 1, CYP26A1  -  cytochrome p450, family 26, subfamily a, polypeptide 1]
GO:0051336	regulation of hydrolase activity	4.63E-4	1.02E-1	1.95	10344	760	195	28	[SERPINA3  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 3, FABP1  -  fatty acid binding protein 1, liver, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), SPP2  -  secreted phosphoprotein 2, 24kda, PLXNC1  -  plexin c1, SERPINA11  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 11, ODAM  -  odontogenic, ameloblast asssociated, AMBP  -  alpha-1-microglobulin/bikunin precursor, PLA2G1B  -  phospholipase a2, group ib (pancreas), CIDEB  -  cell death-inducing dffa-like effector b, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, SERPIND1  -  serpin peptidase inhibitor, clade d (heparin cofactor), member 1, SERPINA6  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 6, APOA5  -  apolipoprotein a-v, VIL1  -  villin 1, NGF  -  nerve growth factor (beta polypeptide), PPP1R1C  -  protein phosphatase 1, regulatory (inhibitor) subunit 1c, SPINK6  -  serine peptidase inhibitor, kazal type 6, TP63  -  tumor protein p63, AHSG  -  alpha-2-hs-glycoprotein, TNF  -  tumor necrosis factor, SERPINB11  -  serpin peptidase inhibitor, clade b (ovalbumin), member 11 (gene/pseudogene), APOC3  -  apolipoprotein c-iii, LIPC  -  lipase, hepatic, MYL4  -  myosin, light chain 4, alkali; atrial, embryonic, SERPINB7  -  serpin peptidase inhibitor, clade b (ovalbumin), member 7, SERPINB2  -  serpin peptidase inhibitor, clade b (ovalbumin), member 2, CCL20  -  chemokine (c-c motif) ligand 20]
GO:0006570	tyrosine metabolic process	5.1E-4	1.1E-1	17.68	10344	9	195	3	[TAT  -  tyrosine aminotransferase, TYR  -  tyrosinase, HPD  -  4-hydroxyphenylpyruvate dioxygenase]
GO:0055081	anion homeostasis	5.3E-4	1.13E-1	7.37	10344	36	195	5	[HNF4A  -  hepatocyte nuclear factor 4, alpha, SLC12A1  -  solute carrier family 12 (sodium/potassium/chloride transporter), member 1, OTC  -  ornithine carbamoyltransferase, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta)]
GO:0006730	one-carbon metabolic process	5.7E-4	1.19E-1	10.10	10344	21	195	4	[CA5A  -  carbonic anhydrase va, mitochondrial, CA7  -  carbonic anhydrase vii, MAT1A  -  methionine adenosyltransferase i, alpha, CA1  -  carbonic anhydrase i]
GO:0009072	aromatic amino acid family metabolic process	5.7E-4	1.18E-1	10.10	10344	21	195	4	[TAT  -  tyrosine aminotransferase, PAH  -  phenylalanine hydroxylase, TYR  -  tyrosinase, HPD  -  4-hydroxyphenylpyruvate dioxygenase]
GO:0003333	amino acid transmembrane transport	6.16E-4	1.25E-1	5.68	10344	56	195	6	[SLC7A9  -  solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9, SLC16A12  -  solute carrier family 16, member 12, SLC6A14  -  solute carrier family 6 (amino acid transporter), member 14, SLC38A8  -  solute carrier family 38, member 8, SLC1A2  -  solute carrier family 1 (glial high affinity glutamate transporter), member 2, SLC36A2  -  solute carrier family 36 (proton/amino acid symporter), member 2]
GO:0071347	cellular response to interleukin-1	6.85E-4	1.37E-1	6.98	10344	38	195	5	[IL17A  -  interleukin 17a, PCK1  -  phosphoenolpyruvate carboxykinase 1 (soluble), FGB  -  fibrinogen beta chain, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, CCL20  -  chemokine (c-c motif) ligand 20]
GO:0043267	negative regulation of potassium ion transport	6.86E-4	1.36E-1	9.64	10344	22	195	4	[KEL  -  kell blood group, metallo-endopeptidase, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, ACTN2  -  actinin, alpha 2, CAV3  -  caveolin 3]
GO:0006721	terpenoid metabolic process	7.45E-4	1.45E-1	5.49	10344	58	195	6	[RDH8  -  retinol dehydrogenase 8 (all-trans), APOC3  -  apolipoprotein c-iii, ALDH8A1  -  aldehyde dehydrogenase 8 family, member a1, LRP2  -  low density lipoprotein receptor-related protein 2, BCMO1  -  beta-carotene 15,15'-monooxygenase 1, CYP26A1  -  cytochrome p450, family 26, subfamily a, polypeptide 1]
GO:0008284	positive regulation of cell proliferation	7.54E-4	1.45E-1	2.15	10344	518	195	21	[PITX2  -  paired-like homeodomain 2, NCCRP1  -  non-specific cytotoxic cell receptor protein 1 homolog (zebrafish), CSF3  -  colony stimulating factor 3 (granulocyte), KLB  -  klotho beta, TAC1  -  tachykinin, precursor 1, LRP2  -  low density lipoprotein receptor-related protein 2, TBX20  -  t-box 20, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), TP63  -  tumor protein p63, CAV3  -  caveolin 3, PRKCQ  -  protein kinase c, theta, PTPRN  -  protein tyrosine phosphatase, receptor type, n, TNF  -  tumor necrosis factor, PPARGC1A  -  peroxisome proliferator-activated receptor gamma, coactivator 1 alpha, ODAM  -  odontogenic, ameloblast asssociated, MAB21L2  -  mab-21-like 2 (c. elegans), ESM1  -  endothelial cell-specific molecule 1, CDX2  -  caudal type homeobox 2, PLA2G1B  -  phospholipase a2, group ib (pancreas), SERPINB7  -  serpin peptidase inhibitor, clade b (ovalbumin), member 7, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled]
GO:0017144	drug metabolic process	7.94E-4	1.5E-1	2.56	10344	311	195	15	[PCK1  -  phosphoenolpyruvate carboxykinase 1 (soluble), ALDH8A1  -  aldehyde dehydrogenase 8 family, member a1, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, BHMT  -  betaine--homocysteine s-methyltransferase, MAT1A  -  methionine adenosyltransferase i, alpha, HPD  -  4-hydroxyphenylpyruvate dioxygenase, ALDH1B1  -  aldehyde dehydrogenase 1 family, member b1, TAT  -  tyrosine aminotransferase, PAH  -  phenylalanine hydroxylase, GCH1  -  gtp cyclohydrolase 1, NR1I2  -  nuclear receptor subfamily 1, group i, member 2, AFP  -  alpha-fetoprotein, URAD  -  ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase, MPO  -  myeloperoxidase]
GO:0006865	amino acid transport	8.13E-4	1.52E-1	4.58	10344	81	195	7	[SLC7A9  -  solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9, SLC16A12  -  solute carrier family 16, member 12, SLC6A14  -  solute carrier family 6 (amino acid transporter), member 14, SLC38A8  -  solute carrier family 38, member 8, ACE2  -  angiotensin i converting enzyme 2, SLC1A2  -  solute carrier family 1 (glial high affinity glutamate transporter), member 2, SLC36A2  -  solute carrier family 36 (proton/amino acid symporter), member 2]
GO:0043086	negative regulation of catalytic activity	8.37E-4	1.54E-1	2.24	10344	450	195	19	[SERPIND1  -  serpin peptidase inhibitor, clade d (heparin cofactor), member 1, SERPINA6  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 6, SERPINA3  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 3, VIL1  -  villin 1, NGF  -  nerve growth factor (beta polypeptide), PPP1R1C  -  protein phosphatase 1, regulatory (inhibitor) subunit 1c, SPINK6  -  serine peptidase inhibitor, kazal type 6, FABP1  -  fatty acid binding protein 1, liver, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), SPP2  -  secreted phosphoprotein 2, 24kda, CAV3  -  caveolin 3, AHSG  -  alpha-2-hs-glycoprotein, TNF  -  tumor necrosis factor, SERPINA11  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 11, APOC3  -  apolipoprotein c-iii, SERPINB11  -  serpin peptidase inhibitor, clade b (ovalbumin), member 11 (gene/pseudogene), AMBP  -  alpha-1-microglobulin/bikunin precursor, SERPINB7  -  serpin peptidase inhibitor, clade b (ovalbumin), member 7, SERPINB2  -  serpin peptidase inhibitor, clade b (ovalbumin), member 2]
GO:1903825	organic acid transmembrane transport	8.75E-4	1.59E-1	4.53	10344	82	195	7	[SLC7A9  -  solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9, SLC16A12  -  solute carrier family 16, member 12, SLC6A14  -  solute carrier family 6 (amino acid transporter), member 14, SLC38A8  -  solute carrier family 38, member 8, LRP2  -  low density lipoprotein receptor-related protein 2, SLC1A2  -  solute carrier family 1 (glial high affinity glutamate transporter), member 2, SLC36A2  -  solute carrier family 36 (proton/amino acid symporter), member 2]
GO:1905039	carboxylic acid transmembrane transport	8.75E-4	1.57E-1	4.53	10344	82	195	7	[SLC7A9  -  solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9, SLC16A12  -  solute carrier family 16, member 12, SLC6A14  -  solute carrier family 6 (amino acid transporter), member 14, SLC38A8  -  solute carrier family 38, member 8, LRP2  -  low density lipoprotein receptor-related protein 2, SLC1A2  -  solute carrier family 1 (glial high affinity glutamate transporter), member 2, SLC36A2  -  solute carrier family 36 (proton/amino acid symporter), member 2]
GO:0051248	negative regulation of protein metabolic process	8.9E-4	1.58E-1	2.00	10344	637	195	24	[SERPIND1  -  serpin peptidase inhibitor, clade d (heparin cofactor), member 1, SERPINA6  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 6, IGF2BP3  -  insulin-like growth factor 2 mrna binding protein 3, IGF2BP1  -  insulin-like growth factor 2 mrna binding protein 1, SERPINA3  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 3, VIL1  -  villin 1, NGF  -  nerve growth factor (beta polypeptide), RPS6KA6  -  ribosomal protein s6 kinase, 90kda, polypeptide 6, PPP1R1C  -  protein phosphatase 1, regulatory (inhibitor) subunit 1c, RNF222  -  ring finger protein 222, SPINK6  -  serine peptidase inhibitor, kazal type 6, FABP1  -  fatty acid binding protein 1, liver, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), SPP2  -  secreted phosphoprotein 2, 24kda, CAV3  -  caveolin 3, AHSG  -  alpha-2-hs-glycoprotein, TNF  -  tumor necrosis factor, PPARGC1A  -  peroxisome proliferator-activated receptor gamma, coactivator 1 alpha, SERPINA11  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 11, SERPINB11  -  serpin peptidase inhibitor, clade b (ovalbumin), member 11 (gene/pseudogene), AMBP  -  alpha-1-microglobulin/bikunin precursor, LMO3  -  lim domain only 3 (rhombotin-like 2), SERPINB7  -  serpin peptidase inhibitor, clade b (ovalbumin), member 7, SERPINB2  -  serpin peptidase inhibitor, clade b (ovalbumin), member 2]
GO:0042592	homeostatic process	9.67E-4	1.69E-1	1.79	10344	917	195	31	[SERPINA3  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 3, TAC1  -  tachykinin, precursor 1, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), TXNDC8  -  thioredoxin domain containing 8 (spermatozoa), SLC12A1  -  solute carrier family 12 (sodium/potassium/chloride transporter), member 1, KEL  -  kell blood group, metallo-endopeptidase, OTC  -  ornithine carbamoyltransferase, PPARGC1A  -  peroxisome proliferator-activated receptor gamma, coactivator 1 alpha, CA7  -  carbonic anhydrase vii, SLC9A2  -  solute carrier family 9, subfamily a (nhe2, cation proton antiporter 2), member 2, PLA2G1B  -  phospholipase a2, group ib (pancreas), NME8  -  nme/nm23 family member 8, TNFRSF13B  -  tumor necrosis factor receptor superfamily, member 13b, HTR2A  -  5-hydroxytryptamine (serotonin) receptor 2a, g protein-coupled, HNF4A  -  hepatocyte nuclear factor 4, alpha, APOA5  -  apolipoprotein a-v, PCK1  -  phosphoenolpyruvate carboxykinase 1 (soluble), EPB42  -  erythrocyte membrane protein band 4.2, SLC30A2  -  solute carrier family 30 (zinc transporter), member 2, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, TP63  -  tumor protein p63, CAV3  -  caveolin 3, HIST1H4L  -  histone cluster 1, h4l, SLC4A1  -  solute carrier family 4 (anion exchanger), member 1, APOC3  -  apolipoprotein c-iii, LIPC  -  lipase, hepatic, ATP2B3  -  atpase, ca++ transporting, plasma membrane 3, NR1I2  -  nuclear receptor subfamily 1, group i, member 2, TRPV5  -  transient receptor potential cation channel, subfamily v, member 5, ATP13A4  -  atpase type 13a4]
GO:0036148	phosphatidylglycerol acyl-chain remodeling	9.74E-4	1.68E-1	14.47	10344	11	195	3	[PLA2G2F  -  phospholipase a2, group iif, PLA2G1B  -  phospholipase a2, group ib (pancreas), PLA2G2E  -  phospholipase a2, group iie]
